Cancer Clinical Trials Support Scheme
Who can apply: Eligible cancer clinical trials must be Phase I, II or III; multi-centre; investigate treatment, prevention or diagnosis of cancer or cancer-related symptoms; receive capitation of no more than $10,000 per patient; and be approved by a NHMRC-registered Institutional Ethics Committee. Grants are directly linked to demonstrated levels of clinical trial activity.